Sachpekidis, Christos; Alberts, Ian; Rominger, Axel; Afshar-Oromieh, Ali (2019). PSMA radioligand therapy in prostate cancer: overview, latest advances and remaining challenges. Immunotherapy, 11(15), pp. 1267-1271. Future Medicine Ltd 10.2217/imt-2019-0146
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
Sachpekidis-2019-Immunotherapy_PSMA radioligand therapy in prostate Cancer.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (664kB) | Request a copy |
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine |
UniBE Contributor: |
Sachpekidis, Christos, Alberts, Ian Leigh, Rominger, Axel Oliver, Afshar Oromieh, Ali |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1750-7448 |
Publisher: |
Future Medicine Ltd |
Language: |
English |
Submitter: |
Sabine Lanz |
Date Deposited: |
23 Jan 2020 14:28 |
Last Modified: |
05 Dec 2022 15:34 |
Publisher DOI: |
10.2217/imt-2019-0146 |
PubMed ID: |
31496329 |
Uncontrolled Keywords: |
actinium-225 (225Ac) lutetium-177 (177Lu) metastatic castration-resistant prostate cancer (mCRPC) prostate-specific membrane antigen (PSMA) radioligand therapy (RLT) |
BORIS DOI: |
10.7892/boris.137420 |
URI: |
https://boris.unibe.ch/id/eprint/137420 |
Actions (login required)
 |
Edit item |